These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21296570)

  • 1. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of Clinical Trials That Stopped Early.
    Viele K; McGlothlin A; Broglio K
    JAMA; 2016 Apr; 315(15):1646-7. PubMed ID: 27092832
    [No Abstract]   [Full Text] [Related]  

  • 4. Early viewing of noninferiority trials in progress.
    Dignam JJ
    J Clin Oncol; 2005 Aug; 23(24):5461-3. PubMed ID: 16027438
    [No Abstract]   [Full Text] [Related]  

  • 5. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of the methodology in cluster randomized trials].
    Kramar A; Bonnetain F; Mathoulin-Pélissier S
    Bull Cancer; 2008 Dec; 95(12):1141-2. PubMed ID: 19108340
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 9. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomised phase II trials in oncology].
    Piedbois P
    Bull Cancer; 2007 Nov; 94(11):953-6. PubMed ID: 18055312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pocock approach to sequential meta-analysis of clinical trials.
    Shuster JJ; Neu J
    Res Synth Methods; 2013 Sep; 4(3):269-79. PubMed ID: 24348752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplicity in oncology randomised controlled trials: a threat to medical evidence?
    Prasad V; Booth CM
    Lancet Oncol; 2019 Dec; 20(12):1638-1640. PubMed ID: 31797779
    [No Abstract]   [Full Text] [Related]  

  • 14. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trials (RCTs)--essentials.
    Chan YH
    Singapore Med J; 2003 Feb; 44(2):60-3. PubMed ID: 14503778
    [No Abstract]   [Full Text] [Related]  

  • 16. How to perform a critical analysis of a randomised controlled trial.
    Estellat C; Torgerson DJ; Ravaud P
    Best Pract Res Clin Rheumatol; 2009 Apr; 23(2):291-303. PubMed ID: 19393572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

  • 18. A guide to sample size and interim analysis in clinical trials.
    Rademaker AW
    Contemp Urol; 1994 Feb; 6(2):43-4. PubMed ID: 10146676
    [No Abstract]   [Full Text] [Related]  

  • 19. Forty years of randomised trials in the New Zealand Medical Journal.
    Neal B; Rodgers A; Mackie MJ; MacMahon S
    N Z Med J; 1996 Oct; 109(1031):372-3. PubMed ID: 8890875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.